Clinical Trial Detail

NCT ID NCT02884648
Title Bevacizumab in Ovarian Cancer Patients With Disease at Second-look Surgery
Recruitment Recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors M.D. Anderson Cancer Center
Indications

peritoneum cancer

fallopian tube cancer

ovary epithelial cancer

Therapies

Bevacizumab

Age Groups: senior adult

No variant requirements are available.